EFNB2 and hepatocellular carcinoma: The study also confirmed the high prevalence of genes known to be deregulated by abnormal methylation in HCC (e.g., RALGDS/AF-6, IGF2, APC) while also identifying potential candidate epidrivers (e.g., SEPT9 and ephrin B2).